Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    Institute of Hematology & Blood Diseases Hospital
Updated on 29 January 2022

Summary

This single-center study aims to study the efficacy and safety of avatrombopag in Chinese adult ITP patients. This study will be conducted in adult ITP patients who had not responded to eltrombopag or rhTPO in the previous treatment .

Description

The primary objective of this study was to evaluate the efficacy and safety of avatrombopag in adult ITP patients who had not responded to eltrombopag or rhTPO in the previous treatment.

20 eligible subjects will be enroll ed in this study.The dose will be adjusted according to the subject platelet count during the period from week 1 to week 8.

Details
Condition Primary Immune Thrombocytopenic Purpura
Treatment Avatrombopag
Clinical Study IdentifierNCT04890041
SponsorInstitute of Hematology & Blood Diseases Hospital
Last Modified on29 January 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note